DOI QR코드

DOI QR Code

Safety and efficacy of novel oblique-viewing scope for B2-endoscopic ultrasound-guided hepaticogastrostomy

  • Sho Ishikawa (Department of Gastroenterology, Aichi Cancer Center Hospital) ;
  • Kazuo Hara (Department of Gastroenterology, Aichi Cancer Center Hospital) ;
  • Nozomi Okuno (Department of Gastroenterology, Aichi Cancer Center Hospital) ;
  • Nobumasa Mizuno (Department of Gastroenterology, Aichi Cancer Center Hospital) ;
  • Shin Haba (Department of Gastroenterology, Aichi Cancer Center Hospital) ;
  • Takamichi Kuwahara (Department of Gastroenterology, Aichi Cancer Center Hospital) ;
  • Yasuhiro Kuraishi (Department of Gastroenterology, Aichi Cancer Center Hospital) ;
  • Takafumi Yanaidani (Department of Gastroenterology, Aichi Cancer Center Hospital) ;
  • Masanori Yamada (Department of Gastroenterology, Aichi Cancer Center Hospital) ;
  • Tsukasa Yasuda (Department of Gastroenterology, Aichi Cancer Center Hospital) ;
  • Toshitaka Fukui (Department of Gastroenterology, Aichi Cancer Center Hospital) ;
  • Teru Kumagi (Post Graduate Medical Education Center, Ehime University Hospital) ;
  • Yoichi Hiasa (Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine)
  • 투고 : 2023.05.16
  • 심사 : 2023.07.07
  • 발행 : 2024.07.30

초록

Background/Aims: Endoscopic ultrasound (EUS)-guided hepaticogastrostomy (EUS-HGS) performed at the intrahepatic bile duct segment 3 (B3) is widely used for biliary drainage. Although performing post-puncture procedures is easier in the intrahepatic bile duct segment 2 (B2) when using a conventional oblique-viewing (OV) EUS scope, this method may cause transesophageal puncture and severe adverse events. We evaluated the safety and efficacy of B2 puncture using a novel OV-EUS scope. Methods: In this single-center retrospective study, we prospectively enrolled and collected data from 45 patients who consecutively underwent EUS-HGS procedures with a novel OV-EUS scope between September 2021 and December 2022 at our cancer center. Results: The technical success rates of B2-EUS-HGS and EUS-HGS were 93.3% (42/45) and 97.8% (44/45), respectively. The early adverse event rate was 8.9% (4/45) with no cases of scope changes or transesophageal punctures. The median procedure time was 13 minutes (range, 5-30). Conclusions: B2-EUS-HGS can be performed safely with the novel EG-740UT (Fujifilm) OV-scope without transesophageal puncture and with a high success rate. B2-EUS-HGS using this novel OV scope may be the preferred strategy for EUS-HGS.

키워드

참고문헌

  1. Hara K, Yamao K, Mizuno N, et al. Endoscopic ultrasonography-guided biliary drainage: who, when, which, and how? World J Gastroenterol 2016;22:1297-1303.
  2. Okuno N, Hara K, Mizuno N, et al. Efficacy of the 6-mm fully covered self-expandable metal stent during endoscopic ultrasound-guided hepaticogastrostomy as a primary biliary drainage for the cases estimated difficult endoscopic retrograde cholangiopancreatography: a prospective clinical study. J Gastroenterol Hepatol 2018;33:1413-1421.
  3. Matsubara S, Nakagawa K, Suda K, et al. Practical tips for safe and successful endoscopic ultrasound-guided hepaticogastrostomy: a state-of-the-art technical review. J Clin Med 2022;11:1591.
  4. Pawa R, Pleasant T, Tom C, et al. Endoscopic ultrasound-guided biliary drainage: are we there yet? World J Gastrointest Endosc 2021;13:302-318.
  5. Vila JJ, Perez-Miranda M, Vazquez-Sequeiros E, et al. Initial experience with EUS-guided cholangiopancreatography for biliary and pancreatic duct drainage: a Spanish national survey. Gastrointest Endosc 2012;76:1133-1141.
  6. Oh D, Park DH, Song TJ, et al. Optimal biliary access point and learning curve for endoscopic ultrasound-guided hepaticogastrostomy with transmural stenting. Therap Adv Gastroenterol 2017;10:42-53.
  7. Isayama H, Nakai Y, Itoi T, et al. Clinical practice guidelines for safe performance of endoscopic ultrasound/ultrasonography-guided biliary drainage: 2018. J Hepatobiliary Pancreat Sci 2019;26:249-269.
  8. Matsumoto S, Hara K, Mizuno N, et al. Risk factor analysis for adverse events and stent dysfunction of endoscopic ultrasound-guided choledochoduodenostomy. Dig Endosc 2020;32:957-966.
  9. Hara K, Okuno N, Haba S, et al. How to perform EUS-guided hepaticogastrostomy easier and safer. J Hepatobiliary Pancreat Sci 2020;27:563-564.
  10. Sekine M, Hashimoto Y, Shibuki T, et al. A retrospective multicenter study comparing the punctures to B2 and B3 in endoscopic ultrasound-guided hepaticogastrostomy. DEN Open 2023;3:e201.
  11. Okuno N, Hara K, Mizuno N, et al. B2 puncture with forward-viewing EUS simplifies EUS-guided hepaticogastrostomy (with video). Endosc Ultrasound 2022;11:319-324.
  12. Tsuchiya T, Itoi T, Sofuni A, et al. Endoscopic ultrasonography-guided rendezvous technique. Dig Endosc 2016;28 Suppl 1:96-101.
  13. Okuno N, Hara K, Mizuno N, et al. Risks of transesophageal endoscopic ultrasonography-guided biliary drainage. Gastrointest Interv 2017;6:82-84.
  14. Ogura T, Itoi T. Technical tips and recent development of endoscopic ultrasound-guided choledochoduodenostomy. DEN Open 2021;1:e8.
  15. Samanta J, Sundaram S, Dhar J, et al. EUS-guided biliary drainage in patients with moderate-severe cholangitis is safe and effective: a multi-center experience. Surg Endosc 2023;37:298-308.
  16. Okuno N, Hara K, Mizuno N, et al. Infectious peritonitis after endoscopic ultrasound-guided biliary drainage in a patient with ascites. Gastrointest Interv 2018;7:40-43.
  17. Okuno N, Hara K, Mizuno N, et al. Stent migration into the peritoneal cavity following endoscopic ultrasound-guided hepaticogastrostomy. Endoscopy 2015;47 Suppl 1 UCTN:E311.
  18. Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010;71:446-454.
  19. Dell'Anna G, Ogura T, Vanella G, et al. Endoscopic ultrasound guided biliary interventions. Best Pract Res Clin Gastroenterol 2022;60-61:101810.